Skip to content
  • Sunday, 26 July 2026
  • 4:38 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Precision Medicine in Early Oncology Trials: Biomarkers as Strategic Drivers – Pharmaceutical Technology
Pharmaceutical R&D

Precision Medicine in Early Oncology Trials: Biomarkers as Strategic Drivers – Pharmaceutical Technology

Teuku Ryan Apr 11, 2026 0

The landscape of oncology drug development is undergoing a profound transformation, increasingly centered on precision immunotherapies where biomarker-defined patient populations…

Read More
Clinical Diagnostics & Pathology

Clinical laboratories should note the growing role of blood-based biomarkers in neurodegenerative disease detection.

Reynand Amr Wu Mar 26, 2026 0

Researchers at Washington University School of Medicine in St. Louis have unveiled a groundbreaking blood-test-based model designed to predict the…

Read More
Neuroscience & Brain Research

Cerebrovascular Function and Oxygen Regulation as Early Biomarkers for Alzheimer’s Disease Risk and Cognitive Decline

Rifan Muazin Mar 24, 2026 0

The intricate relationship between the brain’s vascular health and the onset of neurodegenerative conditions has reached a new milestone with…

Read More
Colon Cancer Cells May Change Identity to Metastasize, Unveiling New Pathways for Therapeutic InterventionTWiV 1293: The enemy of your parasite is your friendPrecision DNA Editing Targets Root Cause of Severe Childhood Epilepsy in Preclinical StudyHigh-Dose Fish Oil Supplements Fail to Slow Cognitive Decline in Older Adults at Risk for Alzheimer’s Disease Despite Successful Brain Penetration
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ